Study ID: IXR-201-19-166
Study Title
- Multicenter Trial For Patients With Acute Crohn's Disease
Teva Identifier
- IXR-201-19-166
ClinicalTrials.gov Identifier
- NCT00035503
Study Status
- Completed
Trial Condition(s)
- Crohn's Disease
Interventions
- Drug: etiprednol dicloacetate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 01/01/2002 - 01/01/2004
Phase
- Phase 2
Study Type
Interventional